AKT1 and prostate cancer: PI3K-Akt-PTEN signaling has been confirmed in previous studies of breast cancer and prostate cancer (Jamaspishvili et al., 2018; Schadendorf et al., 2018; Yang, Polley & Lipkowitz, 2016).